Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
May 4, Congress Center, Basel, CH
March 24-28, Manchester Grand Hyatt, San Diego, CA, USA
March 20 - 22, 2017 - CCIB Convention Centre - Barcelona, Spain